Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy

Hybrid nanocarriers have realized a growing interest in drug delivery research because of the potential of being able to treat, manage or cure diseases that previously had limited therapy or cure. Cancer is currently considered the second leading cause of death globally. This makes cancer therapy a...

Full description

Saved in:
Bibliographic Details
Main Authors: Joan Onyebuchi Erebor, Elizabeth Oladoyin Agboluaje, Ava M. Perkins, Megha Krishnakumar, Ndidi Ngwuluka
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-10-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-14-558.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!